Incidence of mutated DNA damage response pathway and clinically actionable alterations in Chinese patients with unknown primary tumor revealed by comprehensive genomic profiling.
机构：[1]China Japan Union Hosp, Dept Med Oncol, Changchun, Peoples R China[2]Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada[3]Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China[4]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China临床科室肿瘤内科河北医科大学第四医院
第一作者机构：[1]China Japan Union Hosp, Dept Med Oncol, Changchun, Peoples R China[2]Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada[3]Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Shibao,Yu Ruoying,Ou Qiuxiang,et al.Incidence of mutated DNA damage response pathway and clinically actionable alterations in Chinese patients with unknown primary tumor revealed by comprehensive genomic profiling.[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):
APA：
Wang, Shibao,Yu, Ruoying,Ou, Qiuxiang,Wu, Xue,Bao, Hua...&Wei, Suju.(2020).Incidence of mutated DNA damage response pathway and clinically actionable alterations in Chinese patients with unknown primary tumor revealed by comprehensive genomic profiling..JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Wang, Shibao,et al."Incidence of mutated DNA damage response pathway and clinically actionable alterations in Chinese patients with unknown primary tumor revealed by comprehensive genomic profiling.".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学